清创保留假体失败不影响感染全膝关节置换分期翻修的成功率
该多中心回顾性研究纳入291例假体周围感染患者,比较以分期翻修为首次手术者与清创保留假体失败后再行分期翻修者的治疗成功率。平均随访6.2年,失败清创组成功率为72%,仅分期翻修组为81%,竞争风险生存分析显示两组失败概率无显著差异(亚分布风险比=0.72,95%CI 0.32-1.61,P=0.42)。作者认为先前清创保留假体失败不影响后续分期翻修的成功率。
要点
- 清创保留假体失败后再行分期翻修的成功率为72%,仅行分期翻修者为81%。
- 两组失败概率的亚分布风险比为0.72(95%CI 0.32-1.61,P=0.42),无显著差异。
- 作者认为先前清创保留假体失败不损害后续分期翻修的成功率。
核心结论
- 作者认为,先前清创保留假体失败不影响后续分期翻修的成功率。
研究设计与样本
- 多中心回顾性研究,覆盖15年期间,共纳入291例符合条件患者。
- 63例以分期翻修为首次手术治疗假体周围感染,228例以清创保留假体为首次手术。
- 228例清创保留假体患者中75例失败后接受后续分期翻修(F-DAIR组)。
- 治疗成功定义为保留假体且不使用长期抑制性抗生素。
- 采用竞争风险生存分析比较两组,并考虑患者人口学特征、美国麻醉医师协会评分、病原体类型、体重指数、假体年龄和症状持续时间。
主要发现
- 平均随访6.2年,F-DAIR组成功率为72%,仅分期翻修组为81%。
- 竞争风险生存分析显示两组失败概率的亚分布风险比为0.72(95%CI 0.32-1.61,P=0.42),无显著差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Periprosthetic joint infection (PJI) is the leading cause of early revisions after total knee arthroplasty. Debridement, antibiotics, and implant retention (DAIR) procedures are often the initial treatment for PJI. However, there is concern that failed DAIR undermines the future success of revision procedures. This study aims to investigate the impact of DAIR on the success of subsequent staged revisions for PJI. METHODS: A multicenter retrospective review was performed over a 15-year period. Treatment success was defined as implant retention without the use of long-term suppressive antibiotics. This was compared between patients who underwent a staged revision as the first procedure for PJI (staged-only) and patients who failed DAIR before staged revision (F-DAIR). Competing risk survival analysis was performed to compare the 2 groups and considered for patient demographics, American Society of Anesthesiologists score, organism type, body mass index, age of prosthesis, and duration of symptoms. RESULTS: Of 291 eligible patients, 63 underwent staged revision and 228 underwent DAIR as the first procedure for PJI. Of the 228 DAIR patients, 75 failed DAIR and underwent subsequent staged revision (F-DAIR). At mean follow-up of 6.2 years, the success rate was 72% in the F-DAIR group and 81% in the staged-only group. On survival analysis, there was no significant difference in subdistribution hazard ratio comparing the probability of failure (implant retention) in the 2 treatments groups (subdistribution hazard ratio = 0.72; 95% confidence interval 0.32-1.61; P = .42). CONCLUSION: This study suggested that a previously failed DAIR does not compromise the success rate of a subsequent staged revision.
引用
- Kim K, Zhu M, Cavadino A, et al. Failed Debridement and Implant Retention Does Not Compromise the Success of Subsequent Staged Revision in Infected Total Knee Arthroplasty. J Arthroplasty. 2019. PMID: 30826164. doi:10.1016/j.arth.2019.01.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。